Alphatec Spine announces expiration of Hart-Scott-Rodino Review Period for acquisition of Scient’x Groupe


Anticipates closing the transaction by the end of Q1 2010.

Alphatec Holdings, the parent company of Alphatec Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that the Hart-Scott-Rodino (HSR) review period for Alphatec Spine’s proposed acquisition of Scient’x Groupe S.A.S. has expired with no action by the United States Federal Trade Commission (FTC).The expiration of the HSR review period satisfies one of the conditions necessary for the transaction to close. The Company has set February 9, 2010 as the record date for the special meeting of its shareholders to approve the issuance of the shares of its common stock in the transaction. The special meeting of the company’s shareholders will be held on Tuesday, March 16, 2010. Alphatec expects that, subject to the remaining customary closing conditions, the transaction will be completed by the end of the first quarter of 2010.